CBDL (CBD Life Sciences) Research & Development: $0.00 Mil (TTM As of Sep. 2015)


What is CBD Life Sciences Research & Development?

CBD Life Sciences CBDL Research & Development is $0.00 Mil as of Sep. 2015.

Research & Development is the aggregate amount of research and development expenses during the year. CBD Life Sciences's Research & Development for the three months ended in Sep. 2015 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00 Mil.

CBD Life Sciences  (OTCPK:CBDL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CBD Life Sciences Research & Development Related Terms

CBD Life Sciences Research & Development Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences Research & Development Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Research & Development
0.00 0.00 0.00 0.00

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBD Life Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
CBD Life Sciences (CBDL) has a Research & Development of $0.00 Mil as of Sep. 2015. Research and development expense is the total cost for research and development activities. View historical data on CBD Life Sciences and its competitors.
Is CBD Life Sciences' Research & Development too high?
CBD Life Sciences' current Research & Development is $0.00 Mil.
How does CBD Life Sciences' Research & Development compare to QPAG and ADGO?
CBD Life Sciences' Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CBD Life Sciences and its competitors. CBD Life Sciences's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current Research & Development is $0.00 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.